Skip to main content
OpenTrials

Clinical trial condition

Choroid Diseases

Explore clinical trials studying Choroid Diseases. Study availability and eligibility vary by location and protocol.

232 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Choroid Diseases trial results

Active, not recruiting

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

NCT05024695

Conditions
Choroid Diseases, Choroidal Effusions, Eye Abnormalities, +5 more
Locations
  • Arizona Advanced Eye Research Institute Glendale, Arizona, United States
  • Vold Vision Fayetteville, Arkansas, United States
  • Beverly Hills Institute of Ophthalmology Beverly Hills, California, United States
  • Reeve Woods Eye Center Chico, California, United States
View all 37 locations
View Trial Details
Active, not recruiting

Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

NCT05536973

Conditions
Blindness, Choroid Diseases, Choroidal Neovascularization, +16 more
Locations
  • Adverum Clinical Site 178 Phoenix, Arizona, United States
  • Adverum Clinical Site 126 Phoenix, Arizona, United States
  • Adverum Clinical Site 159 Tucson, Arizona, United States
  • Adverum Clinical Site 100 Beverly Hills, California, United States
View all 39 locations
View Trial Details
Completed

A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease

NCT06587828

Conditions
Ankylosing Spondylitis, Ankylosis, Arthritis, +51 more
Locations
  • Knowledge Research Center Orange, California, United States
  • Cura Clinical Research Sherman Oaks, California, United States
  • Arnold Arthritis & Rheumatology Skokie, Illinois, United States
  • University of Kentucky Research Foundation Lexington, Kentucky, United States
View Trial Details
Completed

Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa

NCT03584165

Conditions
Choroid Diseases, Choroideremia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +6 more
Locations
  • UCLA - Jules Stein Eye Institute Los Angeles, California, United States
  • Vitreo Retinal Associates PA - The Millennium Center Gainesville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View all 25 locations
View Trial Details
Completed

A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)

NCT05282953

Conditions
Choroid Diseases, Choroideremia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Save Sight Institute Sydney, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Harley Eye Clinic North Adelaide, South Australia, Australia
View Trial Details
Completed

Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy

NCT05666804

Conditions
Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +16 more
Locations
  • Novartis Investigative Site Daegu, Dalseo Gu, South Korea
  • Novartis Investigative Site Bundang Gu, Gyeonggi-do, South Korea
  • Novartis Investigative Site Daejeon, Korea, South Korea
  • Novartis Investigative Site Seoul, Korea, South Korea
View all 15 locations
View Trial Details

Related conditions